Showing results (11-20 of 109) with videos related to
Sort By:
Pageof 11
BMC Genomics|March 17, 2006
Comparison of the latest commercial short and long oligonucleotide microarray technologiesAurélien de Reyniès, Daniela Geromin, Jean-Michel Cayuela, et al.European Journal of Haematology|May 6, 2015
Novel fusion between the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with chronic myeloid leukemia-like neoplasm: undetectable residual disease after imatinib therapyThomas Cluzeau, Eric Lippert, Jean-Michel Cayuela, et al.La Revue Du Praticien|June 23, 2025
[The contribution of high-throughput sequencing in malignant hematological disorders]Pierre Sujobert, Anne-Sophie Alary, Fanny Baran-Marszak, et al.British Journal of Haematology|August 9, 2019
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practiceFrançoise Huguet, Jean-Michel Cayuela, Nathalie Cambier, et al.European Journal of Haematology|November 22, 2007
Synchronous FIP1L1-PDGFRA-positive chronic eosinophilic leukemia and T-cell lymphoblastic lymphoma: a bilineal clonal malignancyMathieu Capovilla, Jean-Michel Cayuela, Chrystèle Bilhou-Nabera, et al.Bulletin Du Cancer|September 4, 2025
[Recommendations from the GBMHM and the Fi-LMC for the diagnosis and management of chronic myeloid leukemia]Jean-Michel Cayuela, Stéphanie Dulucq, Sandrine Hayette, et al.Blood|June 25, 2024
Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemiaPierre Walczak, Sofiane Fodil, Nicolas Vignal, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 2014
Tc1 clonal T cell expansion during chronic graft-versus-host disease-associated hypereosinophiliaEmmanuel Clave, Aliénor Xhaard, Corrine Douay, et al.Journal of Leukocyte Biology|February 8, 2006
Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activationNicolas Boissel, Philippe Rousselot, Emmanuel Raffoux, et al.Blood|March 19, 2005
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)Jean Soulier, Emmanuelle Clappier, Jean-Michel Cayuela, et al.Pageof 11